Although there is clear significance of ERα and ERβ in the protective role of estrogen in the AD development [5, 10, 20], the Women’s Health Initiative found that estrogen therapy on cognitive function for post-menopausal women is no longer a benefit for treatment [3, 4]. Here, ESR2 is linked to Alzheimer disease.